Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 58
- Pharmaceutical
Roundup of Q1 2022 financial results in the UK medical cannabis space
Companies across the cannabis industry announce financial results for the first quarter of 2022, Cannabis Wealth rounds up the results of six major firms expanding within the UK medical cannabis space. 2021 was a positive year for cannabis businesses with 165 per cent year-over-year growth in cannabis equity capital raises and a series of high…
- Press releases
Khiron Achieves United Kingdom Cannabis Sales Volume Growth Of 240% In Q1 2022
KHIRON Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout Europe and Latin America, continues to demonstrate its market dominance in the UK’s medical cannabis industry with cannabis sales volume growth of 240% in Q1 2022 compared to the entire 2021 year.
- Medical
Police investigate a retail data breach in Ontario
WTF OCS? Police are investigating a retailer data breach at the Ontario Cannabis Store In what Ontario Cannabis Store’s spokesperson is calling “a criminal matter,” police are investigating a potential theft of sensitive cannabis retailer data, per MJBizDaily.
- Adult-Use
Is German Oversupply Hampering Growth Of Its Medical Cannabis Industry?
GERMANY is continuing to see cannabis companies from across the globe pile into its medical cannabis market in the hopes of securing their piece of the pie.
- Press releases
Aurora Launches New EU GMP Extracts To Expand Therapy Options For Cannabis Patients In The United Kingdom
AURORA Cannabis, a pioneer and global leader in the medical cannabis industry, has launched three new cannabis extracts for patients in the United Kingdom.
- Adult-Use
Grow Group Plans IPO In ‘Next 12 Months’ Following German Expansion
GROW Group told BusinessCann back in 2020 that it was raising £6m in capital to fund its expansion across Europe, setting its sights on the German medical cannabis opportunity.
- Cultivation
How dispensary break-ins may shape policy in DC
ABOUT F-ING TIME A ‘wave’ of cannabis burglaries has caught the attention of Capitol Hill A ‘cannabis crime wave’ which has resulted in numerous fatalities could motivate Capitol Hill to approve federal cannabis banking reform, per Politico.
- Medical
The Medical Cannabis Industry Was ‘Started By Patients’ And They Play An ‘Important Role’ In Pushing It Forward
ACCORDING to the most recent figures from Prohibition Partners’ European Cannabis Report, the number of privately prescribed, unlicensed medical cannabis items dispensed in the UK last year jumped 425% to 23,466.
- Press releases
PharmaCielo Partners With Soteria Holdings Limited To License, Import And Wholesale Its Medical Cannabis Flower And Extracts In The Polish Market
PHARMACIELO Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. (“Holdings”), today announced that it has signed an investment agreement (the “Agreement”) with Soteria Holdings Limited (“Soteria”), a UK based portfolio company of Artemis Growth Partners, an…
- Opinion
Akanda’s Tej Virk Has A Message For The Portuguese Government – “Legalise It Before Germany”
As reported by Cannareporter TEJ Virk, CEO of Akanda Corporation, which recently acquired Portugal’s Holigen for €26 million , has gained a reputation in the global cannabis space in recent years after building a solid career in banking and capital markets.
- CBD Market
UK Government must seize cannabis opportunity, says parliamentary group
The UK government has the opportunity plan for the creation of a long-term cannabis industry, the All Party Parliamentary Group (APPG) for CBD Products has stated.
- Companies
Apollon Formularies purchases four patents from Aion Therapeutic
Apollon Formularies has announced the acquisition of four patents previously owned by AI Pharmaceuticals, covering a number of treatments for cancers and inflammation using cannabis and mushroom compositions.
